Chul S. Ha

6.5k citations

145 papers · 4.6k indexed · 1 hit paper · h-index 34

Impact in

Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Hematology top 1%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research

Papers in

Pathology and Forensic Medicine 72
- Lymphoma Diagnosis and Treatment 70
Radiation 24
- Advanced Radiotherapy Techniques 24

Co-authors: James D. Cox Fernando Cabanillas Richard B. Wilder Mark A. Hess Hagop M. Kantarjian Jörge E. Cortes Charles Koller Terry L. Smith
Journals: International Journal of Radiation Oncology*Biology*Physics (38 papers)Cancer (19 papers)Blood (6 papers)Medical Physics (5 papers)Journal of Applied Clinical Medical Physics (5 papers)
Partner nations: United States Greece Canada

In The Last Decade

Chul S. Ha

140 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia 2000 · 586 citations

Peers

Countries citing papers authored by Chul S. Ha

Since Specialization

Citations

This map shows the geographic impact of Chul S. Ha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chul S. Ha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chul S. Ha more than expected).

Fields of papers citing papers by Chul S. Ha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chul S. Ha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chul S. Ha. The network helps show where Chul S. Ha may publish in the future.

Co-authors

The 25 scholars most cited alongside Chul S. Ha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chul S. Ha Line = papers co-authored together Chul S. Ha links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groups The Lancet Haematology ·Omran Saifi, Chelsea C. Pinnix, Leslie K. Ballas, Chris R. Kelsey, Sarah A. Milgrom, Stephanie A. Terezakis, Nicholas Figura, Rahul R. Parikh, J.C. Grecula, Stella Flampouri, Chul S. Ha, Andrea Lo, John P. Plastaras, David Hodgson, Bradford S. Hoppe	2024	3
2	Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816 Leukemia & lymphoma ·Chul S. Ha, Michael LeBlanc, Heiko Schöder, Chelsea C. Pinnix, Nancy L. Bartlett, Andrew M. Evens, Eric D. Hsi, Lisa M. Rimsza, Michael V. Knopp, Jun Zhang, John P. Leonard, Brad S. Kahl, Hongli Li, Sonali M. Smith, Louis S. Constine, Jonathan W. Friedberg	2020	1
3	The effect of radiation therapy on post-prostatectomy urinary function Reports of Practical Oncology & Radiotherapy ·Yaujen Wang, Gregory P. Swanson, Sameer Jhavar, Kristofer R. Wagner, Chul S. Ha, 渡邊真由子	2020	3
4	Commissioning an Elekta Versa HD linear accelerator Journal of Applied Clinical Medical Physics ·G. Narayanasamy, Daniel Saenz, Ziyang Feng, Chul S. Ha, Niko Papanikolaou, S Stathakis	2016	40
5	Multi-Center US Intergroup Study of Intensive Chemotherapy Plus Dasatinib Followed By Allogeneic Stem Cell Transplant in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Younger Than 60 Blood ·Farhad Ravandi, Megan Othus, Susan O’Brien, Stephen J. Forman, Chul S. Ha, Jeffrey Y.C. Wong, Martin S. Tallman, Elisabeth Paietta, Janis Racevskis, Geoffrey L. Uy, Uma Borate, Partow Kebriaei, Laura Kingsbury, Hagop M. Kantarjian, Jerald P. Radich, Harry P. Erba, Frederick R. Appelbaum	2015	11
6	p53‐Based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study Molecular Oncology ·Chul S. Ha, Joel Michalek, Richard Elledge, Kevin R. Kelly, Suthakar Ganapathy, Hang Su, S. T. Lee, Athanassios Argiris, Ronan Swords, Tony Y. Eng, Anand B. Karnad, Richard L. Crownover, Gregory P. Swanson, Martin Goros, Brad H. Pollock, Zhi-Min Yuan	2015	9
7	A Low-dose Arsenic-induced p53 Protein-mediated Metabolic Mechanism of Radiotherapy Protection Journal of Biological Chemistry ·Suthakar Ganapathy, Shaowen Xiao, Mei Yang, Min Qi, Dirk Schulenburg, Chul S. Ha, John B. Little, Mengchen Liu	2014	18
8	Human lymphoma cells develop resistance to radiation in the presence of astrocytes in vitro Zurich Open Repository and Archive (University of Zurich) ·Masashi Koto, 板倉弘恵, Oliver Riesterer, Uma Giri, Michael D. Story, Chul S. Ha, Uma Raju	2011	3
9	Oncodiagnosis panel: 2004 lymphoma Radiographics ·Chul S. Ha, L. Jeffrey Medeiros, Chusilp Charnsangavej, Michael Crump, Mary Gospodarowicz	2006	1
10	Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma Journal of the American Academy of Dermatology ·Madeleine Duvic, Narin Apisarnthanarax, Deborah S. Cohen, Terry L. Smith, Chul S. Ha, Razelle Kurzrock	2003	48
11	Outcomes Using Doxorubicin-Based Chemotherapy with or without Radiotherapy for Early-Stage Peripheral T-cell Lymphomas Leukemia & lymphoma ·Hoon K. Lee, Richard B. Wilder, Dan Jones, Chul S. Ha, Barbara Pro, Maria Alma Rodriguez, Jorge Romaguera, Fernando Cabanillas, José Rodríguez, James D. Cox	2002	12
12	An elevated serum beta‐2‐microglobulin level is an adverse prognostic factor for overall survival in patients with early‐stage Hodgkin disease Cancer ·Gregory M. Chronowski, Richard B. Wilder, Susan L. Tucker, Chul S. Ha, Andreas H. Sarris, Fredrick B. Hagemeister, İbrahim Barışta, Mark A. Hess, Fernando Cabanillas, James D. Cox	2002	35
13	Nasal-Type T/NK Lymphomas: A Clinicopathologic Study of 13 Cases Leukemia & lymphoma ·José A. Rodríguez, Jorge Romaguera, John T. Manning, Nelson G. Ordóǹez, Chul S. Ha, V. Sitakara Rao, Fernando Cabanillas	2000	45
14	The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum International Journal of Radiation OncologyBiologyPhysics ·Upkar Hooda, Chul S. Ha, Mark A. Hess, Jorge Romaguera, John T. Manning, Fernando Cabanillas, James D. Cox	2000	22
15	Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III–IV, intermediate grade and large-cell immunoblastic lymphomas International Journal of Radiation OncologyBiologyPhysics ·Pamela J. Schlembach, Richard B. Wilder, Susan L. Tucker, Chul S. Ha, Maria Alma Rodriguez, Mark A. Hess, Fernando Cabanillas, James D. Cox	2000	24
16	Stages I-III Follicular Lymphoma: Role of CT of the Abdomen and Pelvis in Follow-up Studies Radiology ·Chunli Lu, Chul S. Ha, Barry I. Samuels, Fernando Cabanillas, Mark A. Hess, James D. Cox	1999	22
17	Role of Radiation Therapy to the Brain in Leukemic Patients with Cranial Nerve Palsies in the Absence of Radiological Findings Leukemia & lymphoma ·Chul S. Ha, 鎌田聖一, GILFRAN MELO NASCIMENTO, James D. Cox	1999	8
18	Primary Non-Hodgkin Lymphoma of the Small Bowel Radiology ·Chul S. Ha, Moon-June Cho, Pamela K. Allen, Lillian M. Fuller, Fernando Cabanillas, James D. Cox	1999	16
19	Hodgkin’s disease with lymphocyte predominance: long-term results based on current histopathologic criteria International Journal of Radiation OncologyBiologyPhysics ·Chul S. Ha, Vivek S. Kavadi, Meletios Α. Dimopoulos, Frederick Hagemeister, Daniel Isaacs, Lillian M. Fuller, Terry L. Smith, Mark A. Hess, Peter W. McLaughlin, Fernando Cabanillas, James D. Cox	1999	16
20	Primary parotid lymphoma: the effect of international prognostic index on outcome Leukemia & lymphoma ·Andreas H. Sarris, Vali Papadimitrakopoulou, Meletios Α. Dimopoulos, Terry Smith, William Pugh, Chul S. Ha, Peter McLaughlin, David L. Callender, James D. Cox, Fernando Cabanillas	1997	22

About Chul S. Ha

Chul S. Ha is a scholar working on Pathology and Forensic Medicine, Radiation, Neurology, Genetics and Oncology, having authored 145 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (70 papers), CNS Lymphoma Diagnosis and Treatment (31 papers), Advanced Radiotherapy Techniques (24 papers), Viral-associated cancers and disorders (19 papers), Lung Cancer Treatments and Mutations (15 papers), Chronic Lymphocytic Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (11 papers) and Radiation Therapy and Dosimetry (10 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.9k citations), Hematology (1.1k citations), Oncology (1.8k citations), Genetics (653 citations) and Neurology (925 citations). Chul S. Ha has collaborated with scholars based in United States, Greece and Canada. Frequent co-authors include James D. Cox, Fernando Cabanillas, Richard B. Wilder, Mark A. Hess, Hagop M. Kantarjian, Jörge E. Cortes, Charles Koller, Terry L. Smith, James D. Cox and John T. Manning. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer, Blood, Medical Physics and Journal of Applied Clinical Medical Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact